Analysis of CXCL9 and CXCR3 expression in a case of intravascular large B-cell lymphoma

Journal of the American Academy of Dermatology

Volumn 61, Issue 5, 2009, Pages 888-891

  Kato, Maymi ^a   Ohshima, Koichi ^b   Mizuno, Masahiro ^a   Kyogoku, Masahisa ^a   Hashikawa, Keiko ^b   Tokura, Yoshiki ^c   Miyachi, Yoshiki ^d   Kabashima, Kenji ^d  

^a MITSUBISHI KYOTO HOSPITAL   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^d KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

chemokine; chemokine receptor; CXCL9; CXCR3; intravascular large B cell lymphoma; skin

Indexed keywords

CD20 ANTIBODY; CHEMOKINE RECEPTOR CXCR3; CXCL9 CHEMOKINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; PROTEIN BCL 2; VINCRISTINE;

AGED; ARTICLE; CARCINOGENESIS; CASE REPORT; CHROMATIN; FEMALE; FEVER; HUMAN; HUMAN TISSUE; HYPOTENSION; IMMUNOHISTOCHEMISTRY; INTRAVASCULAR LARGE CELL LYMPHOMA; LARGE CELL LYMPHOMA; LEG EDEMA; PANCYTOPENIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR BIOPSY;

AGED; BIOPSY; CHEMOKINE CXCL9; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, LARGE B-CELL, DIFFUSE; RECEPTORS, CXCR3; SKIN; VASCULAR NEOPLASMS;

EID: 70349840469     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2009.02.007     Document Type: Article

References (9)

1. Pfleger L., and Tappeiner J. On the recognition of systematized endotheliomatosis of the cutaneous blood vessels (reticuloendotheliosisig? [German]. Hautarzt 10 (1959) 359-363
2. Bogomolski-Yahalom V., Lossos I.S., Okun E., Sherman Y., Lossos A., and Polliack A. Intravascular lymphomatosis-an indolent or aggressive entity?. Leuk Lymphoma 29 (1998) 585-593
3. Ponzoni M., Arrigoni G., Gould V.E., Del Curto B., Maggioni M., Scapinello A., et al. Lack of CD 29 (beta1 integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis. Hum Pathol 31 (2000) 220-226
4. Wong S., and Fulcher D. Chemokine receptor expression in B-cell lymphoproliferative disorders. Leuk Lymphoma 45 (2004) 2491-2496
5. Suefuji H., Ohshima K., Karube K., Kawano R., Nabeshima K., Suzumiya J., et al. CXCR3-positive B cells found at elevated frequency in the peripheral blood of patients with MALT lymphoma are attracted by Mig, and belong to the lymphoma clone. Int J Cancer 114 (2005) 896-901
6. Trentin L., Agostini C., Facco M., Piazza F., Perin A., Siviero M., et al. The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis. J Clin Invest 104 (1999) 115-121
7. Jones D., Benjamin R.J., Shahsafaei A., and Dorfman D.M. The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia. Blood 95 (2000) 627-632
8. Ohshima K., Suefuji H., Karube K., Hamasaki M., Hatano B., Tutiya T., et al. Expression of chemokine receptor CXCR3 and its ligand, Mig, in gastric and thyroid marginal zone lymphomas: possible migration and autocrine mechanism. Leuk Lymphoma 44 (2003) 329-336
9. Qin S., Rottman J.B., Myers P., Kassam N., Weinblatt M., Loetscher M., et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 101 (1998) 746-754